Metraipolis › archive › dc_fb32323975a8
Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome — Europe PMC PMID:42647509
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42647509
- DOI
- 10.1371/journal.pone.0349155
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T01:47:14.411Z
- SHA-256 of the archived text
330d7109a60f0315469c3d4ca1508252ffa24b5b43ebe561f9e66ea240d2ca2f- Stable URL of this page
https://metraipolis.com/documento/dc_fb32323975a8
How to cite
Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome — Europe PMC PMID:42647509 — Europe PMC (en), https://europepmc.org/article/MED/42647509 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb32323975a8 (Metraipolis archive dc_fb32323975a8, sha256 330d7109a60f0315469c3d4ca1508252ffa24b5b43ebe561f9e66ea240d2ca2f)
BibTeX
@misc{dcfb32323975a8,
title = {Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome — Europe PMC PMID:42647509},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42647509},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb32323975a8; sha256 330d7109a60f0315469c3d4ca1508252ffa24b5b43ebe561f9e66ea240d2ca2f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42647509. Agents can read the archived copy with the MCP tool read_document.